home / stock / bthcf / bthcf quote
Last: | $ |
---|---|
Change Percent: | 10.19% |
Open: | $0.04 |
Close: | $0.04 |
High: | $0.04 |
Low: | $0.04 |
Volume: | 400 |
Last Trade Date Time: | 12/30/2019 09:43:33 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$ | $0.04 | $0.04 | $0.04 | $0.04 | 400 | 12-30-2019 |
$ | $0.039554 | $0.0363 | $0.0432 | $0.0362 | 609,215 | 12-27-2019 |
$ | $0.041 | $0.041 | $0.041 | $0.041 | 4,000 | 12-26-2019 |
$ | $N/A | $0.04055 | $N/A | $N/A | 0 | 12-25-2019 |
$ | $N/A | $0.04055 | $N/A | $N/A | 0 | 12-24-2019 |
$ | $0.0449 | $0.04055 | $0.0449 | $0.0332 | 13,100 | 12-23-2019 |
$ | $0.04 | $0.04 | $0.0401 | $0.04 | 15,810 | 12-20-2019 |
$ | $0.0371 | $0.037 | $0.0371 | $0.037 | 1,690 | 12-19-2019 |
$ | $0.04305 | $0.0369 | $0.04305 | $0.0369 | 8,100 | 12-18-2019 |
$ | $0.041325 | $0.0387 | $0.0467 | $0.0387 | 63,658 | 12-17-2019 |
$ | $0.0451 | $0.041 | $0.0451 | $0.0353 | 15,750 | 12-16-2019 |
$ | $0.03895 | $0.039 | $0.039 | $0.03895 | 19,513 | 12-13-2019 |
$ | $0.04 | $0.037 | $0.0424 | $0.0369 | 69,700 | 12-12-2019 |
$ | $0.044 | $0.044 | $0.044 | $0.044 | 4,500 | 12-11-2019 |
$ | $0.0398 | $0.0456 | $0.0541 | $0.0398 | 86,021 | 12-10-2019 |
$ | $0.0443 | $0.0446 | $0.0525 | $0.0443 | 16,650 | 12-09-2019 |
$ | $0.05 | $0.0485 | $0.052 | $0.0404 | 67,003 | 12-06-2019 |
$ | $0.046455 | $0.052 | $0.0648 | $0.0444 | 298,288 | 12-05-2019 |
$ | $0.027 | $0.0399 | $0.0399 | $0.027 | 26,700 | 12-04-2019 |
$ | $0.036 | $0.0325 | $0.036 | $0.0291 | 40,750 | 12-03-2019 |
News, Short Squeeze, Breakout and More Instantly...
Breathtec Biomedical Inc Company Name:
BTHCF Stock Symbol:
OTCMKTS Market:
VANCOUVER, British Columbia, May 12, 2021 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCB: BTHCF) (the “ Company ” or “ Algernon ”) a clinical stage pharmaceutical development company announces that NP-120 (Ifenpro...
VANCOUVER, British Columbia, Dec. 16, 2019 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCB: BTHCF) (the “ Company ” or “ Algernon ”), a clinical stage pharmaceutical development company, is pleased to announce that Dr. Mar...
VANCOUVER, British Columbia, Dec. 10, 2019 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCB: BTHCF) (the “ Company ” or “ Algernon ”), a clinical stage pharmaceutical development company, is pleased to announce that it will...